Generated September 3, 2026 at 8:34 PM ET
· Covers September 3 trading day
· 10 of 154 ready 8-Ks selected
· AI-assisted overview
The day's filings featured major M&A activity, including NVIDIA's agreement to acquire Hugging Face for ~$11.9B and Apogee's completion of its $10.9B acquisition by AbbVie, while Bank7 won an auction for Century Financial Services. Regulatory developments included Vaxcyte narrowing its VAX-31 data timeline and appointing new CMO and CLO, Milestone's etripamil receiving its first approval outside the US in China, and Nasdaq compliance issues for Gulf Resources and Nexentis. Earnings reports from Brady, UiPath, and Concrete Pumping Holdings showed revenue growth and positive guidance, with Concrete Pumping initiating a dividend. The filings also included leadership changes and updates on compliance plans, reflecting a mix of corporate actions and regulatory outcomes.
leadership
positive
materiality 0.70
September 3, 2026, 4:18 PM ET
Vaxcyte appoints CMO and CLO; narrows VAX-31 OPUS-1 topline data to end of October 2026
- Luis Jodar, Ph.D., former Pfizer CMO for Vaccines and Infectious Diseases, joins as Chief Medical Officer.
- David McAvoy, J.D., former Teva Chief Legal Officer, joins as Chief Legal Officer; Mikhail Eydelman remains SVP, General Counsel.
- Topline safety, tolerability, and immunogenicity data from VAX-31 Phase 3 OPUS-1 trial now expected by end of October 2026, narrowing prior Q4 guidance.
GURE
GULF RESOURCES, INC.
regulatory
negative
materiality 0.70
September 3, 2026, 4:30 PM ET
Gulf Resources gets Nasdaq extension to file Q2 10-Q; still delinquent
- On Sept 1, 2026, Nasdaq granted extension to regain compliance with Listing Rule 5250(c)(1).
- Sept 2, 2026: Nasdaq confirmed Q1 10-Q no longer delinquent, but Q2 10-Q (June 30) still unfiled.
- Company submitted updated compliance plan on Aug 28, 2026; must file June 30 Form 10-Q by extended deadline.
M&A
positive
materiality 0.95
September 3, 2026, 8:03 AM ET
NVIDIA to acquire Hugging Face for ~$11.9B; close expected H1 2027
- NVIDIA agrees to acquire Hugging Face for ~$11.9B cash to stockholders, plus up to $1.0B equity retention for employees.
- Transaction expected to close in first half of 2027, subject to regulatory approvals and customary closing conditions.
- NVIDIA commits to keep Hugging Face's platform open, including support for other silicon vendors.
M&A
positive
materiality 0.80
September 3, 2026, 4:05 PM ET
Bank7 wins auction for ~71% of Century Financial Services for $91M
- Net cash purchase price ~$89M after $2M breakup fee credit; $91M gross bid.
- Century Bank: $1.36B assets, $1.23B deposits, $845M loans as of June 30, 2026.
- Acquisition creates combined ~$3.4B asset Southwest banking organization.
MIST
Milestone Pharmaceuticals Inc.
regulatory
positive
materiality 0.80
September 3, 2026, 4:03 PM ET
Milestone's etripamil approved in China by NMPA; first approval outside US
- NMPA approved etripamil nasal spray for PSVT in adults on Sept 3, 2026; first approval outside US.
- Approval triggers $2.0M milestone payment to Milestone; Everest Medicines to commercialize in Greater China.
- Milestone eligible for up to $98.0M in milestones and tiered royalties up to 18% on future sales.
APGE
Apogee Therapeutics, Inc.
M&A
neutral
materiality 1.00
September 3, 2026, 8:53 AM ET
Apogee completes $10.9B acquisition by AbbVie; shareholders get $135.11/share
- Merger completed Sept 3, 2026; each share converted to $135.11 cash, total equity value ~$10.9B.
- Company to delist from Nasdaq; trading suspended Sept 4, 2026, Form 25 to be filed.
- All directors resigned; new directors from Merger Sub appointed; execs stepped down.
NXTS
Nexentis Technologies Inc.
regulatory
negative
materiality 0.70
September 3, 2026, 4:05 PM ET
Nexentis gets Nasdaq delisting notice; equity $1.78M vs $2.5M required
- Received Nasdaq letter on Aug 31, 2026 for failing minimum stockholders' equity requirement.
- Stockholders' equity was $1.782M as of June 30, 2026, below the $2.5M minimum.
- Must submit compliance plan by Oct 15, 2026; possible extension to Feb 27, 2027.
earnings
positive
materiality 0.85
September 3, 2026, 6:59 AM ET
Brady Q4 FY26: record annual adj EPS $5.29, +15%; guides FY27 adj EPS $6.25-6.75
- Q4 sales $436.9M (+10.0% YoY, organic +8.4%); adj diluted EPS $1.48 vs $1.26, +17.5%.
- FY26 record: sales $1.66B (+9.8%), adj diluted EPS $5.29 (+15.0%); operating cash flow $244.1M, +35%.
- Completed Aug 3, 2026 acquisition of Honeywell's Productivity Solutions & Services (now IPS); addressable market expands to $14B.
earnings
positive
materiality 0.80
September 3, 2026, 4:23 PM ET
UiPath Q2 FY27: Revenue $410M (+13% YoY), ARR $1.938B (+12%), CFO promoted
- Revenue $410M, up 13% YoY; ARR $1.938B, up 12% YoY; net new ARR $37M; net retention 109%.
- GAAP operating income $32M; non-GAAP operating income $89M; cash $1.405B.
- Q3 FY27 guidance: revenue $440-445M, ARR $1.992-1.997B, non-GAAP op income ~$100M; FY27 revenue $1.789-1.794B, ARR $2.065-2.070B, non-GAAP op income ~$445M.
BBCP
Concrete Pumping Holdings, Inc.
earnings
positive
materiality 0.80
September 3, 2026, 4:07 PM ET
Concrete Pumping Holdings Q3 revenue up 13% to $116.8M, initiates $0.13 dividend
- Q3 FY2026 revenue $116.8M, up 13% YoY; net income $4.9M, up 33%; diluted EPS $0.09 vs $0.07.
- Adjusted EBITDA $30.4M, up 13% YoY; margin 26.0% vs 25.8%; leverage ratio improved to 3.6x from 3.8x.
- Initiated quarterly cash dividend of $0.13/share, payable Oct 2, 2026 to holders of record Sept 18, 2026; ~5.6% initial yield.